BOTHE

Bone Therapeutics Reports First Results of Its Phase IIA Trial for PREOB® in Severe Osteoporosis

BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE) the bone cell therapy company addressing high unmet medical needs in the field of…